|
Market Closed -
Nasdaq
21:00:00 13/08/2026 BST
|
Pre-market 12:00:22 | |||
| 91.48 USD | +0.75% |
|
89.98 | -1.64% |
| 08-13 | Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating | MT |
| 08-04 | Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DEXCOM, INC. | Other Medical Equipment, Supplies & Distribution | +0.75% | +10.19% | +37.83% | +14.41% | -25.54% | 34.52B |  | | |
- Stock Market
- Stocks
- DXCM Stock
- Charts DexCom, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
